Guyana vs Nicaragua: Cause of death, by non-communicable diseases, ages 60+
Guyana
51.9%
in 2021
Nicaragua
52.2%
in 2021
Guyana rank
175th
Nicaragua rank
174th
Cause of death, by non-communicable diseases, ages 60+ over time
- Guyana
- Nicaragua
How they compare
Nicaragua currently reports 52.2% against 51.9% in Guyana, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Nicaragua ahead.
Guyana ranks 175th and Nicaragua ranks 174th of 185 countries.
Across the 3 decades both report, Guyana averaged higher in 1 and Nicaragua in 2.
Head to head by decade
| Decade | Guyana | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.1% | 89.4% | 6.3% | Nicaragua |
| 2010s | 84.9% | 91.7% | 6.7% | Nicaragua |
| 2020s | 63.7% | 54.3% | 9.4% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Guyana or Nicaragua?
- Nicaragua, at 52.2% against 51.9% in Guyana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Guyana and Nicaragua?
- 0.3%, with Nicaragua ahead.
- How many years of comparable data are there for Guyana and Nicaragua?
- 6 years are reported by both, from 2000 to 2021.
- How do Guyana and Nicaragua rank globally for cause of death, by non-communicable diseases, ages 60+?
- Guyana ranks 175th and Nicaragua ranks 174th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.